Bydureon vs. Ozempic: Is Switching From Exenatide Worth It?

Is Byetta or Bydureon still available in the US?

No, not as brands. AstraZeneca stopped selling Byetta on October 25, 2024, and Bydureon BCise three days later. Both were business decisions, not safety recalls. The FDA then withdrew Byetta's approval on September 3, 2025, because it was no longer sold. The original Bydureon pen, before BCise, had been off the market since 2021.

What's left is narrow. Amneal's generic of twice-daily exenatide, approved in November 2024, is still sold. So if you took Byetta, a version of your drug still exists. If you took Bydureon or Bydureon BCise, the once-weekly form, there is no generic and no brand. You can't fill that prescription in the US today.

Some coupon sites still list Bydureon savings cards. A card can't help when no pharmacy stocks the drug. Treat any Bydureon coupon as out of date.

Which costs less: generic exenatide or Ozempic?

Generic exenatide isn't the budget option it sounds like. With a GoodRx coupon, it costs about $450 a month. Without one, pharmacies charge about $775 to $945. As a generic, it has no maker's savings card.

• With commercial insurance and type 2 diabetes: Ozempic with Novo Nordisk's savings card, as little as $25 a month.
• No insurance, no needle: the Ozempic pill from NovoCare, about $150 to $300 a month by dose. It used to be sold as Rybelsus.
• No insurance, weekly pen: Ozempic from NovoCare, about $350 a month up to 1 mg and about $500 at 2 mg. New patients pay about $200 for each of the first two fills, through December 31, 2026.
• On Medicare with type 2 diabetes: your Part D plan covers Ozempic. In 2026, you pay at most $2,100 a year for covered drugs.
• Paying cash and open to compounding: compounded semaglutide through Fridays, about $150 a month on a prepaid year or about $280 month to month.

The Ozempic list price is about $1,000 a month, the price before any discount. Almost no one pays it. It is set to drop to $675 on January 1, 2027. Ozempic cost breaks down every price tier, and the cheapest Ozempic options ranks the lowest-cost routes.

Compounded semaglutide is the same active ingredient as Ozempic, mixed by a compounding pharmacy for one patient. It is not FDA-approved Ozempic. At Fridays, the price includes visits, shipping and coaching.

Is switching from Bydureon or Byetta to Ozempic actually worth it?

For most women in this spot, yes, and for Bydureon users the choice is already made. The weekly drug you started on no longer exists. The twice-daily generic costs about as much as Ozempic's cash price, without a savings card. And semaglutide beat exenatide in the one trial that tested them side by side.

None of that makes Byetta or Bydureon bad drugs. They were the first GLP-1 medicines and helped many people for over a decade. But the newer molecule does more and costs the same or less through the right channel.

Does Ozempic work better than exenatide for blood sugar and weight?

Yes, and a direct trial shows it. In SUSTAIN 3, 813 adults with type 2 diabetes were randomly assigned to semaglutide 1.0 mg or exenatide ER 2 mg for 56 weeks. A1C, the three-month blood sugar average, fell 1.5 points on semaglutide and 0.9 on exenatide. Weight fell about 5.6 kilograms on semaglutide, against 1.9 on exenatide. Two in three people on semaglutide got their A1C under 7%, against four in ten on exenatide.

Exenatide ER wasn't weak on its own. In its first big trial, DURATION-1, the weekly shot lowered A1C by 1.9 points at 30 weeks. Semaglutide simply moved the bar further when the two were tested in the same study.

Are the side effects different?

The core side effects are shared, because both drugs work the same way. Nausea, vomiting, diarrhea and constipation happen with either, mostly after a dose change. In SUSTAIN 3, stomach and gut side effects were a bit more common on semaglutide: 41.8% against 33.3% on exenatide.

Exenatide's own issue is the injection site. In the same trial, 22% of people on exenatide had injection-site reactions, against about 1% on semaglutide. Its label lists small, firm bumps under the skin as common. Some fade on their own, and others last for months. Exenatide also triggers antibodies more often, which can blunt the drug in some people. For Ozempic's own side effects and how long they last, see Ozempic side effects.

What's actually different between exenatide and semaglutide?

Both are GLP-1 receptor agonists. They slow digestion, quiet appetite signals in the brain and help the pancreas release insulin when blood sugar is high. The difference is where they come from. Exenatide copies exendin-4, a peptide first found in Gila monster saliva. It shares only about half its structure with your own GLP-1.

Semaglutide started from human GLP-1 and was changed just enough to last longer in the blood. It matches the natural hormone by more than 90%. A molecule closer to your own is less likely to trigger your immune system. The changes also help it last a full week per dose.

Weekly Bydureon, twice-daily Byetta, weekly Ozempic: how the shots differed

Byetta was a shot of 5 or 10 micrograms, twice a day. You took it within an hour before two main meals, at least six hours apart. Bydureon put the same drug into a slow-release form taken once a week at 2 mg, with no link to meals. The original Bydureon pen had to be mixed by hand. BCise made that a single-step autoinjector.

Ozempic is also a weekly pen, not tied to meals. The difference is the start. Ozempic begins at a low dose and steps up over several weeks so your gut can adjust. Bydureon started at its full 2 mg from day one.

How do you switch from exenatide to Ozempic?

The switch itself is routine for a prescriber. A few points are worth raising at that visit.

• The overlap window. Weekly exenatide releases slowly from a deposit under the skin. Some can stay active for weeks after your last dose.
• Side effects restart, they don't stack. Ozempic begins at its own low dose. Most people find the first weeks feel like starting any GLP-1.
• Your plan's step rules. Some plans want proof that exenatide failed or isn't available before they approve Ozempic. With Bydureon discontinued, that proof is usually easy.
• A fair trial period. A1C and weight changes take weeks to show on any GLP-1. Don't judge the switch by the first few shots.

Does insurance cover Ozempic more easily than exenatide?

Byetta, Bydureon, Bydureon BCise and Ozempic are all approved for type 2 diabetes. None has ever been approved for weight loss. So unlike Ozempic and Wegovy, there's no label gap that splits coverage here.

In practice, coverage has moved toward Ozempic anyway. Insurers built transition plans when exenatide was discontinued. UnitedHealthcare's 2024 provider notice named Mounjaro, Ozempic, Rybelsus and Trulicity as preferred replacements on its commercial plans. For many former exenatide patients, Ozempic is the route their insurer already favors.

Does this matter differently in perimenopause or menopause?

Falling estrogen tends to worsen insulin resistance and push fat toward the belly. That's why blood sugar medicines and midlife weight come up together so often. Exenatide and semaglutide act on the same GLP-1 pathway, so neither works differently because of menopause.

No trial has looked at a perimenopausal or postmenopausal group for either drug. So there's no menopause-specific verdict to report. The practical point stands: you can't plan the next ten years around a drug that's no longer made.

Which one is right for you? Verdict by profile

• You're on Bydureon or Bydureon BCise: there's nothing left to refill. Ozempic or another GLP-1 is the path forward.
• You're on Byetta and it works: the generic still exists. It costs close to Ozempic's cash pen price, with no savings card, so compare both.
• You want the strongest A1C and weight results: semaglutide won the SUSTAIN 3 head-to-head trial.
• Twice-daily shots were the problem: Ozempic's weekly pen, or its daily pill with no needle, solves that.
• You have commercial insurance and type 2 diabetes: the savings card, as little as $25 a month, likely beats exenatide's coupon price.
• You pay cash and accept compounding: compounded semaglutide costs less than the exenatide generic, though it is not FDA-approved.